EGFR testing in lung cancer is ready for prime time

被引：203
|
作者：
Hirsch, Fred R. [1 ]
Bunn, Paul A., Jr. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
LANCET ONCOLOGY | 2009年 / 10卷 / 05期
关键词：
GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; PHASE-III; MUTATIONS; GEFITINIB; PREDICTORS; CETUXIMAB;
D O I：
10.1016/S1470-2045(09)70110-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：432 / 433
页数：2
相关论文
共 50 条
  • [1] Lung Cancer Screening: Ready for Prime Time?
    Peres, Judy
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (02):
  • [2] Prognostic markers in lung cancer: is it ready for prime time?
    Zhu, Chang-Qi
    Tsao, Ming-Sound
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (03) : 149 - 158
  • [3] Is CT Screening for Lung Cancer Ready for Prime Time?
    Henschke, Claudia I.
    JOURNAL OF THORACIC IMAGING, 2011, 26 (01) : 5 - 6
  • [4] Dual targeting of EGFR: ready for prime time?
    Gan, Hui K.
    Burgess, Antony W.
    Parslow, Adam C.
    Scott, Andrew M.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S18 - S21
  • [5] Spiral CT for lung cancer screening: Is it ready for prime time?
    Jain, P
    Arroliga, AC
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (01) : 74 - 81
  • [6] A lung cancer molecular prognostic test ready for prime time
    Xie, Yang
    Minna, John D.
    LANCET, 2012, 379 (9818): : 785 - 787
  • [7] Lung autoantibodies: Ready for prime time?
    Milross, Luke
    Hachem, Ramsey
    Levine, Deborah
    Glanville, Allan R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02): : 179 - 181
  • [8] ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?
    Pellini, Bruna
    Chaudhuri, Aadel A.
    CLINICAL CANCER RESEARCH, 2023, 29 (12) : 2176 - 2178
  • [9] Blood-based biomarkers for lung cancer: Ready for prime time?
    Vachani, Anil
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S14 - S14
  • [10] ALK-Targeted Therapy for Lung Cancer: Ready for Prime Time
    Husain, Hatim
    Rudin, Charles M.
    ONCOLOGY-NEW YORK, 2011, 25 (07): : 597 - 601
12345